Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 12:59 AM
Ignite Modification Date: 2025-12-25 @ 11:12 PM
NCT ID: NCT05230693
Description: Patients were queried at month 0,1,3,6 regrading any perceived potential negative impact on the patient's health of using the smartphone app
Frequency Threshold: 0
Time Frame: 6 months
Study: NCT05230693
Study Brief: SPARC Smartphone Application for the Management of Sarcoidosis-Associated Fatigue
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
SPARC Group Sarcoidosis Patient Assessment and Resource Companion App: The first group, called the "SPARC group" will be asked to download the SPARC app onto the participant's smartphone, will be shown how to use the app, and then will be asked to use the app to do guided meditations for ten minutes twice a day 0 None 0 25 0 25 View
Enhanced Standard Care Control Group Enhanced Standard Care: Participants will receive education about reducing fatigue associated with sarcoidosis during a normal clinic visit. 0 None 0 25 0 25 View
Serious Events(If Any):
Other Events(If Any):